1. Home
  2. HURA vs PNBK Comparison

HURA vs PNBK Comparison

Compare HURA & PNBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURA
  • PNBK
  • Stock Information
  • Founded
  • HURA 2009
  • PNBK 1999
  • Country
  • HURA United States
  • PNBK United States
  • Employees
  • HURA N/A
  • PNBK N/A
  • Industry
  • HURA
  • PNBK Major Banks
  • Sector
  • HURA
  • PNBK Finance
  • Exchange
  • HURA Nasdaq
  • PNBK Nasdaq
  • Market Cap
  • HURA 131.8M
  • PNBK 124.5M
  • IPO Year
  • HURA N/A
  • PNBK N/A
  • Fundamental
  • Price
  • HURA $2.29
  • PNBK $1.36
  • Analyst Decision
  • HURA Strong Buy
  • PNBK
  • Analyst Count
  • HURA 2
  • PNBK 0
  • Target Price
  • HURA $11.50
  • PNBK N/A
  • AVG Volume (30 Days)
  • HURA 181.8K
  • PNBK 219.5K
  • Earning Date
  • HURA 11-13-2025
  • PNBK 11-18-2025
  • Dividend Yield
  • HURA N/A
  • PNBK N/A
  • EPS Growth
  • HURA N/A
  • PNBK N/A
  • EPS
  • HURA N/A
  • PNBK N/A
  • Revenue
  • HURA N/A
  • PNBK $15,640,000.00
  • Revenue This Year
  • HURA N/A
  • PNBK N/A
  • Revenue Next Year
  • HURA N/A
  • PNBK N/A
  • P/E Ratio
  • HURA N/A
  • PNBK N/A
  • Revenue Growth
  • HURA N/A
  • PNBK N/A
  • 52 Week Low
  • HURA $1.80
  • PNBK $0.90
  • 52 Week High
  • HURA $7.20
  • PNBK $7.47
  • Technical
  • Relative Strength Index (RSI)
  • HURA 39.99
  • PNBK 49.08
  • Support Level
  • HURA $2.16
  • PNBK $1.19
  • Resistance Level
  • HURA $2.61
  • PNBK $1.46
  • Average True Range (ATR)
  • HURA 0.13
  • PNBK 0.10
  • MACD
  • HURA -0.02
  • PNBK 0.02
  • Stochastic Oscillator
  • HURA 25.51
  • PNBK 55.56

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

Share on Social Networks: